gamida cell stock target price

Stock news by MarketWatch. Gamida Cell Ltd.


Gmda Stock Price And Chart Nasdaq Gmda Tradingview

Six investment analysts have rated the.

. Price Targets are an analysts best guess at where the stock will trade in 12 months. Gamida Cell has a twelve month low of 147 and a twelve month high of 472. The average price target is 1575.

Needham Company LLC lowered their target price on Gamida Cell from 1200 to. Not an offer or recommendation by Stocktwits. GMDA was reported by Needham on November 16.

The latest price target for Gamida Cell NASDAQ. GMDA stock opened at 172 on Thursday. GMDA the leader in the development of NAM-enabled cell therapy candidates for patients with hematologic and solid cancers and other serious.

The current analyst and expert consensus on Gamida Cell is Buy with 0 strong sell and 4 strong buy opinions. To contextualize these metrics consider that out of stocks in the small market cap category. The 5 analysts offering 12-month price forecasts for Gamida Cell Ltd have a median target of 1500 with a high estimate of 2200 and a low estimate of 700.

Stock price fell by -166 on the last day Friday 7th Oct 2022 from 181 to 178It has now fallen 3 days in a row. What is the target price for Gamida Cell GMDA stock. The lowest target is.

The company has a quick ratio of 257 a current ratio. Stock quote stock chart quotes analysis advice financials and news for share GAMIDA CELL LTD. The latest price target for.

The Gamida Cell Ltd. GMDA was reported by Needham on Thursday September 29 2022. Gamida Cell Ltd 184 008 455 3rd Party Ad.

Gamida Cell Ltd NASDAQ Updated Oct 13 2022 1131 PM. 2 Wall Street analysts that have issued a 1 year GMDA price target the average GMDA price target is 1200. During the last trading day the.

GMDA Complete Gamida Cell Ltd. The 3 analysts offering price forecasts for Gamida Cell have a median target of 1367 with a high estimate of 1500 and a low estimate of 1200. The average Gamida Cell stock price prediction forecasts a.

Price Target Based on short-term price targets offered by five analysts the average price target for Gamida Cell comes to 1360. The fund acquired 32081 shares of the companys stock valued at approximately 57000. View real-time stock prices and stock quotes for a full financial overview.

The forecasts range from a low of 800 to a high of 2200. GMDA Stock Price Prediction. The current projected Gamida Cell target price consensus is 146 with 5 analyst.

Piper Sandler raised their price target on shares of Gamida Cell from 600 to 800 in a research report on Monday August 15th. GAMIDA CELL LTDs average analyst price target is higher than 11813 of all US stocks. According to 12 stock analysts the average 12-month stock price forecast for Gamida Cell stock is 151 which predicts an increase of 77791.

Gamida Cell started at buy with. GAMIDA CELL LTD. 80000 Upside Based on 5 Wall Street analysts offering 12 month price targets for Gamida Cell in the last 3 months.

Gamida Cell NASDAQGMDA Get Rating had its price target cut by Piper Sandler from 800 to 700 in a report issued on Monday The Fly reports.


Gamida Cell


Gamida Cell Stock Recapping A Tough Year Nasdaq Gmda Seeking Alpha


S002295x16 Graphic6 Jpg


Gamida Cell Ltd Trade Ideas Nasdaq Gmda Tradingview


Gmda Institutional Ownership And Shareholders Gamida Cell Ltd Nasdaq Stock


Gamida Cell Stock Nasdaq Gmda Quotes And News Summary Benzinga


Stock Investing Club Free 7 Day Trial Romero Mentoring


Gamida Cell Ltd Precio Accion Bourse Gmda Il0011552663 Marketscreener


Cmn Markets Cmn Markets May 2021 Open Access Edition Crispr Medicine


Gamida Cell S Cell Therapy Treatment Gains Breakthrough Status


Gamida Cell Stock Gearing Up For Fda Approval Nasdaq Gmda Seeking Alpha


Sec Filing Investors Gamida Cell Ltd


Gamida Set For Breakthrough Transplant Therapy Approval But Cash Problems Could Hit Launch Scrip


These 2 Penny Stocks Are Poised For A Big Rally Says Oppenheimer


Sec Filing Investors Gamida Cell Ltd


Rbc Sees 40 Plus Upside In These 3 Stocks


S002295x16 Graphic12 Jpg


Institutional Owners May Consider Drastic Measures As Gamida Cell Ltd S Nasdaq Gmda Recent Us 41m Drop Adds To Long Term Losses Simply Wall St News


Gamida Cell Stock Gearing Up For Fda Approval Nasdaq Gmda Seeking Alpha

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel